Anti-inflammatory Mechanism of Geniposide: Inhibiting the Hyperpermeability of Fibroblast-Like Synoviocytes via the RhoA/p38MAPK/NF-κB/F-Actin Signal Pathway

MLA

Ran Deng, et al. “Anti-Inflammatory Mechanism of Geniposide: Inhibiting the Hyperpermeability of Fibroblast-Like Synoviocytes via the RhoA/P38MAPK/NF-ΚB/F-Actin Signal Pathway.” Frontiers in Pharmacology, vol. 9, Feb. 2018. EBSCOhost, https://doi.org/10.3389/fphar.2018.00105.

APA

Ran Deng, Feng Li, Hong Wu, Wen-yu Wang, Li Dai, Zheng-rong Zhang, & Jun Fu. (2018). Anti-inflammatory Mechanism of Geniposide: Inhibiting the Hyperpermeability of Fibroblast-Like Synoviocytes via the RhoA/p38MAPK/NF-κB/F-Actin Signal Pathway. Frontiers in Pharmacology, 9. https://doi.org/10.3389/fphar.2018.00105

Chicago

Ran Deng, Feng Li, Hong Wu, Wen-yu Wang, Li Dai, Zheng-rong Zhang, and Jun Fu. 2018. “Anti-Inflammatory Mechanism of Geniposide: Inhibiting the Hyperpermeability of Fibroblast-Like Synoviocytes via the RhoA/P38MAPK/NF-ΚB/F-Actin Signal Pathway.” Frontiers in Pharmacology 9 (February). doi:10.3389/fphar.2018.00105.